Potential effects of logistics clusters: The case of Turkish Freight Villages

Freight Villages (FV) are logistics clusters in which all activities related with freight transportation are realized. Various operators conduct business under one roof in FVs. Coordination and collaboration are the essential part for creating harmony to achieve sustainability. The establishment of such facilities in Turkey has been realized in late 2000s. In this paper, the aim is to provide a broad overview of the FVs in Turkey and shed light into their potential for the future. To do so site visits to all existing operational public FVs and a private FV have been made, where interviews with the management units have been conducted and comparisons to global counterparts have been made. As a result of these, it has been observed that currently, FVs in Turkey are overwhelmed due to lack of coordination and collaboration. However, also light has been shed into possible alternative working principles for Turkish FVs, and it has been showed that if coordination and collaboration could be realized, significant positive effects can be achieved in terms of different aspects regarding sustainability and social equity

Freight villages: A literature review from the sustainability and societal equity perspective

The purpose of this study is to present a state-of-the-art literature review on Freight Villages from the sustainability and equity perspective, and discuss their impacts and place in the supply chain and logistics networks while focusing on the core concepts of freight transportation. With an understanding of the structure of freight villages, it is clear that they have potential for a number of merits with the increase in freight transportation activities. However, our review shows that current literature does not present satisfying evidence that these villages fulfill their purpose in terms of sustainability and social equity

COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission

OBJECTIVE: As the pandemic continues, different vaccine protocols have been implemented to maintain the protection of vaccines and to provide protection against new variants. The aim of this study was to assess hospitalized patients’ vaccination status and document the efficacy of boosters. PATIENTS AND METHODS: The patients that were hospitalized due to COVID-19 were enrolled from 28 hospitals in Turkey for five months from September 2021. 5,331 confirmed COVID-19 patients from collaborating centers were randomly enrolled to understand/estimate the distribution of vaccination status in hospitalized patients and to compare the efficacy of vaccination/booster protocols. RESULTS: 2,779 men and 2,552 women of which 2,408 (45.2%) were admitted to Intensive Care Units participated in this study. It was found that the highest risk reduction for all age groups was found in groups that received 4 doses. Four doses of vaccination for every 3.7 people under 50 years of age, for every 5.7 people in the 50-64 age group, and for every 4.3 people over 65 years of age will prevent 1 patient from being admitted to intensive care. Regardless of the type of vaccine, it was found that the risk of ICU hospitalization decreased in those who were vaccinated compared to those who were not vaccinated. Regardless of the type of vaccine, the ICU risk was found to decrease 1.25-fold in those who received 1 or 2 doses of vaccine, 1.18-fold in those who received 3 doses, and 3.26-fold in those who received 4 doses. CONCLUSIONS: The results suggested that the addition of a fourth dose is more effective in preventing intensive unit care even in disadvantaged groups

COVID-19: booster(s) vs. hospitalization and Intensive Care Unit admission.

OBJECTIVE: As the pandemic continues, different vaccine protocols have been implemented to maintain the protection of vaccines and to provide protection against new variants. The aim of this study was to assess hospitalized patients' vaccination status and document the efficacy of boosters. PATIENTS AND METHODS: The patients that were hospitalized due to COVID-19 were enrolled from 28 hospitals in Turkey for five months from September 2021. 5,331 confirmed COVID-19 patients from collaborating centers were randomly enrolled to understand/estimate the distribution of vaccination status in hospitalized patients and to compare the efficacy of vaccination/booster protocols. RESULTS: 2,779 men and 2,552 women of which 2,408 (45.2%) were admitted to Intensive Care Units participated in this study. It was found that the highest risk reduction for all age groups was found in groups that received 4 doses. Four doses of vaccination for every 3.7 people under 50 years of age, for every 5.7 people in the 50-64 age group, and for every 4.3 people over 65 years of age will prevent 1 patient from being admitted to intensive care. Regardless of the type of vaccine, it was found that the risk of ICU hospitalization decreased in those who were vaccinated compared to those who were not vaccinated. Regardless of the type of vaccine, the ICU risk was found to decrease 1.25-fold in those who received 1 or 2 doses of vaccine, 1.18-fold in those who received 3 doses, and 3.26-fold in those who received 4 doses. CONCLUSIONS: The results suggested that the addition of a fourth dose is more effective in preventing intensive unit care even in disadvantaged